Chemical and Biological Evaluation of Hydrolysis Products of Cyclophosphamide

Journal of Medicinal Chemistry

Volumn 37, Issue 23, 1994, Pages 3986-3993

  Gilard, Véronique ^a,b,c   Martino, Robert ^a,b,c   Malet Martino, Marie C ^a,b,c   Kutscher, Bernhard ^a,b,c   Müller, Arndt ^a,b,c   Niemeyer, Ulf ^a,b,c   Pohl, Jörg ^a,b,c   Polymeropoulos, Emmanuel E ^a,b,c  

^a UNIVERSITÉ PAUL SABATIER   (France)

^b ASTA MEDICA AG   (Germany)

^c EVONIK INDUSTRIES AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOPHOSPHAMIDE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG DECOMPOSITION; DRUG HYDROLYSIS; DRUG METABOLISM; DRUG STABILITY; DRUG STRUCTURE; INTRAPERITONEAL DRUG ADMINISTRATION; LEUKEMIA CELL LINE; MALE; MOUSE; NONHUMAN; PH; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

ANIMAL; CYCLOPHOSPHAMIDE; DRUG SCREENING ASSAYS, ANTITUMOR; DRUG STABILITY; HYDROGEN-ION CONCENTRATION; HYDROLYSIS; LETHAL DOSE 50; LEUKEMIA L1210; LEUKEMIA P388; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICE; SOLUTIONS; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED; WATER;

EID: 0028034986     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm00049a018     Document Type: Article

References (15)

1. Brock, N. Oxazaphosphorine cytostatics: past-present-future. Seventh Cain Memorial award lecture. Cancer Res. 1989, 49, 1-7.
2. Arnold, H.; Klose, A. Die Hydrolyse hexacyclischer N-Lostphosphamidester im gepufferten System. (Hydrolysis of Hexacyclic N-Mustardphosphamide Esters in Buffered Systems.) Arzneim.-Forsch. 1960, 10, 288-291.
3. Arnold, H.; Klose, A. Uber den hydrolytischen Abbau des hexacyclischen N-Lostphosphamidesters B 518 unter physiologischen Bedingungen. (Studies on the Hydrolytic Breakdown of the Hexacyclic N-Mustard Phosphamide Ester B518 in Physiological Conditions.) Arzneim.-Forsch. 1961, 11, 159-163.
4. Arnold, H.; Bourseaux, F. Synthese des N,N-bis-(2-chloroathyl)-O-(3-aminopropyl)-phosphorsäureamidoesters. (The Synthesis of N,N-bis-(2-chloroethyl)-O-(3-aminopropyl)-phosphoric acid amide ester.) Arzneim.-Forsch. 1963, 13, 927-928.
5. Friedman, O. M.; Bien, S.; Chakrabarti, J. K. Studies on the hydrolysis of cyclophosphamide. I. Identification of N-(2-hydroxyethyl)-N′-(3-hydroxypropyl)ethylenediamine as the main product. J. Am. Chem. Soc. 1965, 87, 4978-4979.
6. Chakrabarti, J. K.; Friedman, O. M. Studies on the hydrolysis of cyclophosphamide. II. Isolation and characterization of intermediate hydrolytic products. J. Heterocycl. Chem. 1973, 10, 55-58.
7. Zon, G.; Ludeman, S. M.; Egan, W. High-resolution nuclear magnetic resonance investigation of the chemical stability of cyclophosphamide and related phosphoramidic compounds. J. Am. Chem. Soc. 1977, 99, 5785-5795.
8. Pankiewicz, K.; Kinas, R.; Stec, W. J.; Foster, A. B.; Jarman, M.; Van Maanen, J. M. S. Synthesis and absolute configuration assignments of enantiomeric forms of ifosphamide, sulfosphamide, and trofosphamide. J. Am. Chem. Soc. 1979, 101, 7712-7718.
9. MOPAC (Version 5.0). Quantum Chemistry Program Exchange, No. 455, 1989.
10. Smith, A. E.; Lindner, H. J. Π-SCF-Molecular Mechanics PIMM: Formulation, parameters, applications. J. Comput.-Aided Mol. Des. 1991, 5, 235-262.
11. Brickmann, J.; Waldherr-Teschner, M. Interaktive Computergrafik und Molekulmodellierung. (Interactive Computer Graphic and Molecular Modeling.) Informationstecnhik 1991, 33, 83-90.
12. Hirata, M.; Kagawa, H.; Baba, M. Studies on cyclophosphamide, Part 1. Chemical determination and degradation kinetics in aqueous media. Shionogi Kenkyusho Nenpo 1967, 107-113.
13. Brooke, D.; Bequette, R. J.; Davis, R. E. Chemical stability of cyclophosphamide in parenteral solutions. Am. J. Hasp. Pharm. 1973, 30, 134-137.
14. Katyshkina, V. V.; Kraft, M. Y. The preparation of chlorides and esters of arylphosphoric acids. Zh. Obshch. Khim. 1956, 26, 3407-3412.
15. Hamburger, A. W.; Salmon, S. E. Primary bioassay of human myeloma stem cells. J. Clin. Invest. 1977, 60, 846-854.